Amino acid substitutions in the hepatitis C virus core region of genotype 1b affect very early viral dynamics during treatment with telaprevir, peginterferon, and ribavirin. (Q42994827)

From Wikidata

Jump to navigation Jump to search

scientific article published in April 2010

Language	Label	Description	Also known as
English	Amino acid substitutions in the hepatitis C virus core region of genotype 1b affect very early viral dynamics during treatment with telaprevir, peginterferon, and ribavirin.	scientific article published in April 2010

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20166188%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Amino acid substitutions in the hepatitis C virus core region of genotype 1b affect very early viral dynamics during treatment with telaprevir, peginterferon, and ribavirin (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20166188%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

1 reference

based on heuristic

inferred from title

Hepatitis C virus

1 reference

based on heuristic

inferred from title

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20166188%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Hiromitsu Kumada

14

object named as

Hiromitsu Kumada

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20166188%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Fumitaka Suzuki

2

object named as

Fumitaka Suzuki

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20166188%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

13

object named as

Kenji Ikeda

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20166188%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Masahiro Kobayashi

9

object named as

Masahiro Kobayashi

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20166188%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Yoshiyuki Suzuki

7

object named as

Yoshiyuki Suzuki

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20166188%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

1

object named as

Norio Akuta

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20166188%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

12

object named as

Yasuji Arase

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20166188%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

6

object named as

Hitomi Sezaki

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20166188%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

11

object named as

Satoshi Saitoh

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20166188%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Yusuke Kawamura

4

object named as

Yusuke Kawamura

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20166188%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Mariko Kobayashi

10

object named as

Mariko Kobayashi

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20166188%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

author name string

Miharu Hirakawa

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20166188%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Hiromi Yatsuji

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20166188%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

publication date

1 April 2010

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20166188%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Journal of Medical Virology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20166188%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

82

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20166188%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20166188%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

575-582

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20166188%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Association of amino acid substitution pattern in core protein of hepatitis C virus genotype 1b high viral load and non-virological response to interferon-ribavirin combination therapy.

1 reference

https://api.crossref.org/works/10.1002%2FJMV.21741

21 January 2018

Predictive factors of early and sustained responses to peginterferon plus ribavirin combination therapy in Japanese patients infected with hepatitis C virus genotype 1b: amino acid substitutions in the core region and low-density lipoprotein cholest

1 reference

https://api.crossref.org/works/10.1002%2FJMV.21741

21 January 2018

Prediction of response to pegylated interferon and ribavirin in hepatitis C by polymorphisms in the viral core protein and very early dynamics of viremia.

1 reference

https://api.crossref.org/works/10.1002%2FJMV.21741

21 January 2018

Amino acid substitutions in the hepatitis C virus core region are the important predictor of hepatocarcinogenesis.

1 reference

https://api.crossref.org/works/10.1002%2FJMV.21741

21 January 2018

A matched case-controlled study of 48 and 72 weeks of peginterferon plus ribavirin combination therapy in patients infected with HCV genotype 1b in Japan: amino acid substitutions in HCV core region as predictor of sustained virological response.

1 reference

https://api.crossref.org/works/10.1002%2FJMV.21741

21 January 2018

Amino acid substitutions in the hepatitis C virus core region of genotype 1b are the important predictor of severe insulin resistance in patients without cirrhosis and diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1002%2FJMV.21741

21 January 2018

Expression of hepatitis c virus proteins inhibits interferon alpha signaling in the liver of transgenic mice

1 reference

https://api.crossref.org/works/10.1002%2FJMV.21741

21 January 2018

Hepatitis C virus core protein down-regulates transcription of interferon-induced antiviral genes.

1 reference

https://api.crossref.org/works/10.1002%2FJMV.21741

21 January 2018

Pretreatment Sequence Diversity Differences in the Full-Length Hepatitis C Virus Open Reading Frame Correlate with Early Response to Therapy

1 reference

https://api.crossref.org/works/10.1002%2FJMV.21741

21 January 2018

The natural course of chronic hepatitis C: implications for clinical practice

1 reference

https://api.crossref.org/works/10.1002%2FJMV.21741

21 January 2018

Sequence variation in hepatitis C virus nonstructural protein 5A predicts clinical outcome of pegylated interferon/ribavirin combination therapy

1 reference

https://api.crossref.org/works/10.1002%2FJMV.21741

21 January 2018

Comparison of full-length sequences of interferon-sensitive and resistant hepatitis C virus 1b. Sensitivity to interferon is conferred by amino acid substitutions in the NS5A region

1 reference

https://api.crossref.org/works/10.1002%2FJMV.21741

21 January 2018

Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection

1 reference

https://api.crossref.org/works/10.1002%2FJMV.21741

21 January 2018

Mutations in the hepatitis C virus core gene are associated with advanced liver disease and hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FJMV.21741

21 January 2018

Antiviral activity of telaprevir (VX-950) and peginterferon alfa-2a in patients with hepatitis C.

1 reference

https://api.crossref.org/works/10.1002%2FJMV.21741

21 January 2018

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1002%2FJMV.21741

21 January 2018

Telaprevir and peginterferon with or without ribavirin for chronic HCV infection

1 reference

https://api.crossref.org/works/10.1002%2FJMV.21741

21 January 2018

Impact of daily high-dose IFNalpha-2b plus ribavirin combination therapy on reduction of ALT levels in patients with chronic hepatitis C with genotype 1 and high HCV RNA levels.

1 reference

https://api.crossref.org/works/10.1002%2FJMV.21741

21 January 2018

Disease progression and hepatocellular carcinogenesis in patients with chronic viral hepatitis: a prospective observation of 2215 patients

1 reference

https://api.crossref.org/works/10.1002%2FJMV.21741

21 January 2018

Molecular cloning of the human hepatitis C virus genome from Japanese patients with non-A, non-B hepatitis

1 reference

https://api.crossref.org/works/10.1002%2FJMV.21741

21 January 2018

Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin. Irish Hepatology Research Group

1 reference

https://api.crossref.org/works/10.1002%2FJMV.21741

21 January 2018

Antiviral effects and safety of telaprevir, peginterferon alfa-2a, and ribavirin for 28 days in hepatitis C patients

1 reference

https://api.crossref.org/works/10.1002%2FJMV.21741

21 January 2018

In vitro studies of cross-resistance mutations against two hepatitis C virus serine protease inhibitors, VX-950 and BILN 2061.

1 reference

https://api.crossref.org/works/10.1002%2FJMV.21741

21 January 2018

Discovery and development of VX-950, a novel, covalent, and reversible inhibitor of hepatitis C virus NS3.4A serine protease

1 reference

https://api.crossref.org/works/10.1002%2FJMV.21741

21 January 2018

First phase viral kinetic parameters and prediction of response to interferon alpha-2b/ribavirin combination therapy in patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1002%2FJMV.21741

21 January 2018

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

1 reference

https://api.crossref.org/works/10.1002%2FJMV.21741

21 January 2018

Telaprevir with peginterferon and ribavirin for chronic HCV genotype 1 infection

1 reference

https://api.crossref.org/works/10.1002%2FJMV.21741

21 January 2018

Expression of hepatitis C virus core protein inhibits interferon-induced nuclear import of STATs

1 reference

https://api.crossref.org/works/10.1002%2FJMV.21741

21 January 2018

Mutations in E2-PePHD, NS5A-PKRBD, NS5A-ISDR, and NS5A-V3 of Hepatitis C Virus Genotype 1 and Their Relationships to Pegylated Interferon-Ribavirin Treatment Responses

1 reference

https://api.crossref.org/works/10.1002%2FJMV.21741

21 January 2018

Prognosis of chronic hepatitis C: results of a large, prospective cohort study.

1 reference

https://api.crossref.org/works/10.1002%2FJMV.21741

21 January 2018

Predictive values of amino acid sequences of the core and NS5A regions in antiviral therapy for hepatitis C: a Japanese multi-center study

1 reference

https://api.crossref.org/works/10.1002%2FJMV.21741

21 January 2018

Rapid loss of hepatitis C virus genotype 1b from serum in patients receiving a triple treatment with telaprevir (MP-424), pegylated interferon and ribavirin for 12 weeks.

1 reference

https://api.crossref.org/works/10.1002%2FJMV.21741

21 January 2018

Early viral kinetics and treatment outcome in combination of high-dose interferon induction vs. pegylated interferon plus ribavirin for naive patients infected with hepatitis C virus of genotype 1b and high viral load.

1 reference

https://api.crossref.org/works/10.1002%2FJMV.21741

21 January 2018

SOCS-1 and SOCS-3 inhibit IFN-alpha-induced expression of the antiviral proteins 2,5-OAS and MxA.

1 reference

https://api.crossref.org/works/10.1002%2FJMV.21741

21 January 2018

Telaprevir, peginterferon alfa-2a, and ribavirin for 28 days in chronic hepatitis C patients.

1 reference

https://api.crossref.org/works/10.1002%2FJMV.21741

21 January 2018

Phenotypic and structural analyses of hepatitis C virus NS3 protease Arg155 variants: sensitivity to telaprevir (VX-950) and interferon alpha

1 reference

https://api.crossref.org/works/10.1002%2FJMV.21741

21 January 2018

Identifiers

10.1002/JMV.21741

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20166188%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20166188%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42994827&oldid=1760908690"